These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11521512

  • 41. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP, Korting HC, Viguié-Vallanet C, Larnier C, Savaluny E.
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [Abstract] [Full Text] [Related]

  • 42. A Phase 2, Controlled, Dose-Ranging Study of SB208, an Investigational Topical Nitric Oxide-Releasing Drug, for the Treatment of Tinea Pedis.
    Elewski BE, Kircik LH, Stasko N, De Leon E, Enloe C, Durham T, Maeda-Chubachi T.
    J Drugs Dermatol; 2018 Aug 01; 17(8):888-893. PubMed ID: 30124729
    [Abstract] [Full Text] [Related]

  • 43. Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis.
    Smith EB, Breneman DL, Griffith RF, Hebert AA, Hickman JG, Maloney JM, Millikan LE, Sulica VI, Dromgoole SH, Sefton J.
    J Am Acad Dermatol; 1992 Jan 01; 26(1):125-7. PubMed ID: 1732321
    [No Abstract] [Full Text] [Related]

  • 44. 2% Miconazole nitrate powder in aerosol spray form: its efficacy in treating tinea pedis.
    Shellow WV.
    J Int Med Res; 1982 Jan 01; 10(1):28-31. PubMed ID: 7060822
    [Abstract] [Full Text] [Related]

  • 45. Usefulness of lanoconazole (Astat) cream in the treatment of hyperkeratotic type tinea pedis. Comparative study of monotherapy and combination therapy with 10% urea ointment (Pastaron).
    Tanuma H, Tanuma M, Abe M, Kume H.
    Mycoses; 2001 Jan 01; 44(5):181-90. PubMed ID: 11486456
    [Abstract] [Full Text] [Related]

  • 46. KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs.
    Tatsum Y, Yokoo M, Arika T, Yamaguchi H.
    Microbiol Immunol; 2002 Jan 01; 46(7):425-32. PubMed ID: 12222928
    [Abstract] [Full Text] [Related]

  • 47. TOLNAFTATE IN DERMATOLOGY: A NEW, POTENT TOPICAL FUNGICIDE.
    GOULD AH.
    Dermatol Trop Ecol Geogr; 1964 Jan 01; 18():255-9. PubMed ID: 14277312
    [No Abstract] [Full Text] [Related]

  • 48. Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.
    Kezutyte T, Drevinskas T, Maruska A, Rimdeika R, Briedis V.
    Acta Pol Pharm; 2011 Jan 01; 68(6):965-73. PubMed ID: 22125963
    [Abstract] [Full Text] [Related]

  • 49. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials.
    Stein Gold LF, Parish LC, Vlahovic T, Plaum S, Kircik L, Fleischer AB, Verma A, Olayinka B, Hardas B.
    J Drugs Dermatol; 2013 Aug 01; 12(8):911-8. PubMed ID: 23986165
    [Abstract] [Full Text] [Related]

  • 50. Once-daily luliconazole cream 1% for the treatment of interdigital tinea pedis.
    Gold MH, Olin JT.
    Expert Rev Anti Infect Ther; 2015 Aug 01; 13(12):1433-40. PubMed ID: 26559086
    [Abstract] [Full Text] [Related]

  • 51. Topical treatment of tinea pedis using 6% coriander oil in unguentum leniens: a randomized, controlled, comparative pilot study.
    Beikert FC, Anastasiadou Z, Fritzen B, Frank U, Augustin M.
    Dermatology; 2013 Aug 01; 226(1):47-51. PubMed ID: 23466353
    [Abstract] [Full Text] [Related]

  • 52. Anti-dermatophytic activity of bakuchiol: in vitro mechanistic studies and in vivo tinea pedis-inhibiting activity in a guinea pig model.
    Lau KM, Wong JH, Wu YO, Cheng L, Wong CW, To MH, Lau CP, Yew DT, Leung PC, Fung KP, Hui M, Ng TB, Lau CB.
    Phytomedicine; 2014 Jun 15; 21(7):942-5. PubMed ID: 24703327
    [Abstract] [Full Text] [Related]

  • 53. Therapeutic efficacy of AS2077715 against experimental tinea pedis in guinea pigs in comparison with terbinafine.
    Ohsumi K, Murai H, Nakamura I, Watanabe M, Fujie A.
    J Antibiot (Tokyo); 2014 Oct 15; 67(10):717-9. PubMed ID: 24865864
    [Abstract] [Full Text] [Related]

  • 54. New topical agents for dermatophytosis.
    Smith EB.
    Cutis; 1976 Jan 15; 17(1):54-8. PubMed ID: 1037098
    [Abstract] [Full Text] [Related]

  • 55. Dose-finding comparative study of 2 weeks of luliconazole cream treatment for tinea pedis--comparison between three groups (1%, 0.5%, 0.1%) by a multi-center randomised double-blind study.
    Watanabe S, Takahashi H, Nishikawa T, Takiuchi I, Higashi N, Nishimoto K, Kagawa S, Yamaguchi H, Ogawa H.
    Mycoses; 2007 Jan 15; 50(1):35-40. PubMed ID: 17302746
    [Abstract] [Full Text] [Related]

  • 56. Use of tolnaftate powder in the treatment and prophylaxis of foot mycoses.
    Balogh E, Nagy E, Mészáros C.
    Ther Hung; 1988 Jan 15; 36(2):86-7. PubMed ID: 3201392
    [No Abstract] [Full Text] [Related]

  • 57. Efficacy and safety of once-daily luliconazole 1% cream in patients ≥12 years of age with interdigital tinea pedis: a phase 3, randomized, double-blind,vehicle-controlled study.
    Jarratt M, Jones T, Adelglass J, Bucko A, Pollak R, Roman-Miranda A, Olin JT, Swinyer L.
    J Drugs Dermatol; 2014 Jul 15; 13(7):838-46. PubMed ID: 25007368
    [Abstract] [Full Text] [Related]

  • 58. [New therapy of tinea unguium: ODT (occlusive dressing technic) using 20% urea ointment and an antifungal agent].
    Ishii M, Hamada T, Asai Y.
    Nihon Hifuka Gakkai Zasshi; 1982 Jun 15; 92(7):737-42. PubMed ID: 6217362
    [No Abstract] [Full Text] [Related]

  • 59. An experimental model for evaluation of antifungal agents in a Trichophyton mentagrophytes infection of guinea pigs.
    Valiant ME, Frost BM.
    Chemotherapy; 1984 Jun 15; 30(1):54-60. PubMed ID: 6319091
    [Abstract] [Full Text] [Related]

  • 60. Efficacy, tolerability and consumer acceptability of terbinafine topical spray versus terbinafine topical solution: a phase IIa, randomised, observer-blind, comparative study.
    Brown M, Evans C, Muddle A, Turner R, Lim S, Reed J, Traynor M.
    Am J Clin Dermatol; 2013 Oct 15; 14(5):413-9. PubMed ID: 23740211
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.